Carbamate prodrugs of N-alkylfuramidines
Authors:
- Richard R. TidwellRTRichard R. Tidwell
- Susan K. JonesSJSusan K. Jones
- James E. HallJHJames E. Hall
- David W. BoykinDBDavid W. Boykin
- 1 January 2008
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 43 (1) , 174-177
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Factor VIIa inhibitors: A prodrug strategy to improve oral bioavailabilityBioorganic & Medicinal Chemistry Letters, 2006
- XimelagatranDrugs of Today, 2006
- Recent advances in antitrypanosomal chemotherapy: patent literature 2002 – 2004Expert Opinion on Therapeutic Patents, 2005
- Aromatic diamidines as antiparasitic agentsExpert Opinion on Investigational Drugs, 2005
- Dications That Target the DNA Minor Groove: Compound Design and Preparation, DNA Interactions, Cellular Distribution and Biological ActivityCurrent Medicinal Chemistry - Anti-Cancer Agents, 2005
- Modulators of the Coagulation Cascade: Focus and Recent Advances in Inhibitors of Tissue Factor, Factor VIIa and their ComplexCurrent Medicinal Chemistry, 2005
- Lessons Learned from Marketed and Investigational ProdrugsJournal of Medicinal Chemistry, 2004
- Orally Active GPIIb/IIIa Antagonists. Synthesis and Biological Activities of Masked Amidines as Prodrugs of 2-[(3S)-4-[(2S)-2-(4-Amidinobenzoylamino)-3-(4-methoxyphenyl)propanoyl]-3-(2-methoxy-2-oxoethyl)-2-oxopiperazinyl] acetic Acid.Chemical and Pharmaceutical Bulletin, 2001
- Anti-pneumocystis activity of bis-amidoximes and bis-o-alkylamidoximes prodrugsBioorganic & Medicinal Chemistry Letters, 1996
- Orally Active Fibrinogen Receptor Antagonists. 2. Amidoximes as Prodrugs of AmidinesJournal of Medicinal Chemistry, 1996